Skip to content

CONMED CNMD Total Equity

Total Equity at other companies

Boston Scientific logo
Boston ScientificBSX
$25.86B+16.4%
Vericel logo
VericelVCEL
$356.23M+20.6%
OSI Systems logo
OSI SystemsOSIS
$894.32M+1.7%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$12.67B+2.2%
Medtronic logo
MedtronicMDT
$49.46B+3.0%
Johnson & Johnson logo
Johnson & JohnsonJNJ

Other financials

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total assets$2.3B+0.8%

Cash flow

See full
Operating cash flow$13.5M-67.6%
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation

See full
Market cap$1.07B-34.0%
Enterprise value$1.89B-23.5%
P/E19.4×+5.8×
P/S0.8×-0.5×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp
FCF margin9%-3.5pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Debt / equity0.8×-0.1×
Current ratio2.3×0.0×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CONMED's total equity?
CONMED (CNMD) reported total equity of $1.02B in Q1 2026.
How has CONMED's total equity changed year-over-year?
CONMED's total equity increased by 4.1% year-over-year, from $977.64M to $1.02B.
What is the long-term trend for CONMED's total equity?
Over 5 years (2020 to 2025), CONMED's total equity has grown at a 7.8% compound annual growth rate (CAGR), from $709.04M to $1.03B.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.